1. Barret Ap. Oral mucosal complications in cancer chemotherapy. AustNZJMed 1984;14:7-12.
2. Bergman OJ. Alternations in Oral microflora and Pathogenesis of Acute Oral Infections during Remission - Induction therapy in Patients with Acute Myeloid leukaemia. Scand J Infect Dis 1991;23:355-66.
3. Berkowitz RJ, Feretti GA, Berg JH, Dental Management of Children with Cancer. Pediatric Annals 1988;17:715-25.
4. Bottomley WK; Perlin E, Ross GR. Antineoplastic agents and their oral manifestations. Oral Surg. 1977;44:527-34.
5. Dreizen S, McCredie KB, Keating MJ, Bodey GP. Oral infections associated with chemotherapy, in adults with acute leukemia. Postgraduate Medicine 1982;71:133-43.
6. Dreizen S, McCredie KB, Keating MJ. Chemotherapy - associated oral hemorrhages in adulstwith acute leukemia. Oral Surg 1984;57:494-8.
7. Dreizen S, McCredie KB, Bodey GP, Keating MJ. Quantitative analyis of the oral complications of antileukemia chemotherapy. Oral Surg Oral Med Oral Pathol 1986;62:650-3.
8. Kempin S. Disorders of hemostatis. In: GroegerJS, Critical care of the cancer patient. 2nd ed. St. Louis, Baltimore: Mosby Year Book 1991;103-139.
9. Lindquist SF, Hickey AD, Drane JB. Effect of oral hygiene on stomatitis İn patients receiving cancer chemotherapy. J Prosthet Dent 1978;40:312-14.
10. Loprizİni CL, Cianflone SG, Dose AM, et al. A controlled evaluation of anallopurinal mouthwash as prophylaxis against 5-Flourouracil induced stomatitis. Cancer 1990;65:1879-1882.
11. McGraw WT, Belch A. Oral complications of acute leukemia: Prophylactic impact of a chlorhexidine mouth rinse regimen Oral Surg Oral Med Oral Pathol 1985;60:275-80.
12. Naylor GD. Oral Complications of cancer chemotherapy: Prevention and management. Spacial Care in Dentistry 1988;150-6.
13. Peterson DE. Pretreatment strategies for infection prevention in chemotherapy patient. NCI Monographs 1990;9:61-71.
14. Pierri MK. Heart disease. In: GroegerJS. Critical care of the cancer patient. 2nd. ed. St. Louis, Baltimore: Mosby Year Book. 1991;44-85.
15. Powis GD, Hacker MP. The toxicity of anticancer drugs. New York: Pergamon press, 1991;l-9.
16. Pursel KJ, Telzak EE. Infectious complications of ne-oplastik disease in the intensive care unit. In: GroegerJS. Critical of the cancer patient. 2nd. ed. St. Louis, Baltimore; Mosby Year Book, 1991;40-63.
17. Rutkauskas JS, Davis JW, Effects of chlorhexidine during immunosupressive chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol 1993;76:441-8.
18. Scully C, Cawson RA. Medical problems in dentisry. 2nd. ed. Bristol: Wright. 1987;117-154.
19. Sharon AE, Berdicevsky I, Ben-Aryeh H et al. The effect of chlorhexidine mouth rinses on oral Candida in a group of leukemic patients Oral Surgl977;44:201-5.
20. Sommer SE. The performance and controversies in the immunocompromised and thrombocytopenic patient. In: Greoger JS. Critical care of the cancer patient. 2nd. ed. St Louis, Baltimore: Mosby Year Book, 1991;236-249.
21. Sonis ST, Sonis Al, Lieberman A. Oral complications in patients receiving treatment for malignancies other than of the head and neck./ADA 1978;97:468-72.
22. Sonis ST, Fazio RL, Fang L. Principles and practice of oral medicine 2nd ed Philadelphia: Saunders Co. 1995;426-54.
Thank you for copying data from http://www.arastirmax.com